Recent Articles
Official Cameron Inquiry Report Released
- By Cameron Inquiry
- Published 03/1/2009
- General
- Unrated
The Official Report of the Cameron Inquiry into the Breast Cancer Scandal in Newfoundland and Labrador is to be released on Monday, March 2, 2009. The Cameron Inquiry Report is expected to generate much discussion over the next several weeks and critics are concerned that the report will not be released in full by the Newfoundland and Labrador government.
Gene Helps Breast Cancer Spread
- By Cameron Inquiry
- Published 01/10/2009
- Breast Cancer Research
- Unrated
Researchers have found a gene that makes breast cancer tumors more likely to resist treatments such as chemotherpay and more likely to spread to other organs. Terming this new gene as the "metastasis gene", researchers have found this in 30-40% of the breast cancer patients.
Avastin plus Chemotherapy Improves Progression-Free Survival in Advanced Breast Cancer
- By Cameron Inquiry
- Published 12/1/2008
- Breast Cancer Research
- Unrated
Avastin when combined with chemotherapy has shown results that indicate a longer progression-free interval in advanced breast cancer patients than chemotherapy alone. These results were from a Phase III clinical trial and showed Avastin treatment for HER2-negative breast cancer was effective.
Combat Breast Cancer through Early Detection
- By Cameron Inquiry
- Published 10/20/2008
- Miscellaneous
- Unrated
With one in every eight American women developing breast cancer, one of the best methods of combating breast cancer is through developing an awareness of the disease and how early detection is imperative to survival. Regular breast exams play an important role in combating breast cancer, especially for women who are 40 years old or more.
Presence of Growth Factor Predicts Poor Breast Cancer Outcome
- By Cameron Inquiry
- Published 09/11/2008
- Breast Cancer Research
- Unrated
The response of Breast Cancer to insulin-like growth factor 1 (IGF-1) predicts an aggressive breast cancer tumor that is less likely to respond to treatment. This was the result of breast cancer research conducted by researchers at the Baylor College of Medicine.